Does IBRITUMOMAB TIUXETAN Cause Mucosal inflammation? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Mucosal inflammation have been filed in association with IBRITUMOMAB TIUXETAN (Zevalin). This represents 9.3% of all adverse event reports for IBRITUMOMAB TIUXETAN.
56
Reports of Mucosal inflammation with IBRITUMOMAB TIUXETAN
9.3%
of all IBRITUMOMAB TIUXETAN reports
32
Deaths
33
Hospitalizations
How Dangerous Is Mucosal inflammation From IBRITUMOMAB TIUXETAN?
Of the 56 reports, 32 (57.1%) resulted in death, 33 (58.9%) required hospitalization, and 7 (12.5%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBRITUMOMAB TIUXETAN. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does IBRITUMOMAB TIUXETAN Cause?
Sepsis (123)
Meningitis tuberculous (111)
Off label use (83)
Thrombocytopenia (75)
Myelodysplastic syndrome (72)
Progressive multifocal leukoencephalopathy (62)
Neutropenia (55)
Anaemia (53)
Febrile neutropenia (49)
Acute myeloid leukaemia (44)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which IBRITUMOMAB TIUXETAN Alternatives Have Lower Mucosal inflammation Risk?
IBRITUMOMAB TIUXETAN vs IBRUTINIB
IBRITUMOMAB TIUXETAN vs IBUPROFEN
IBRITUMOMAB TIUXETAN vs IBUPROFEN LYSINE
IBRITUMOMAB TIUXETAN vs IBUPROFEN UNKNOWN PRODUCT
IBRITUMOMAB TIUXETAN vs IBUPROFEN\IBUPROFEN